Clinical Trial Update: C-Cog in Early Course Schizophrenia Study [Phase 4]

View source ↗

Summary

Phase 4 trial of C-Cog in early-course schizophrenia was terminated; results have been posted (2026-02-06).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizophrenia

Drugs mentioned

• C-Cog

Snippet

Sponsor: University of Miami | Conditions: Schizophrenia | Phase 4 | Status: TERMINATED | Results posted: 2026-02-06